Protein oxidation and degradation during aging: Role in skin aging and neurodegeneration

References

• Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 1990; 65: 375–398
   PubMed Web of Science ®Google Scholar
• Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298–300
   PubMedGoogle Scholar
• Dubey A, Forster MJ, Sohal RS. Effect of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone on protein oxidation and life span. Arch Biochem Biophys 1995; 324: 249–254
   PubMed Web of Science ®Google Scholar
• Aksenova MV, Aksenov MY, Carney JM, Butterfield DA. Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing Dev 1998; 100: 157–168
   PubMed Web of Science ®Google Scholar
• Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc Natl Acad Sci USA 1991; 88: 10540–10543
   PubMed Web of Science ®Google Scholar
• Lee DW, Yu BP. Modulation of free radicals and superoxide dismutases by age and dietary restriction. Aging (Milano) 1990; 2: 357–362
   PubMedGoogle Scholar
• Yu BP, Lim BO, Sugano M. Dietary restriction downregulates free radical and lipid peroxide production: Plausible mechanism for elongation of life span. J Nutr Sci Vitaminol (Tokyo) 2002; 48: 257–264
   PubMedGoogle Scholar
• Scrofano MM, Shang F, Nowell TR, Jr., Gong X, Smith DE, Kelliher M, Dunning J, Mura CV, Taylor A. Aging, calorie restriction and ubiquitin-dependent proteolysis in the livers of Emory mice. Mech Ageing Dev 1998; 101: 277–296
   PubMed Web of Science ®Google Scholar
• Dubey A, Forster MJ, Lal H, Sohal RS. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 1996; 333: 189–197
   PubMed Web of Science ®Google Scholar
• Bulteau AL, Szweda LI, Friguet B. Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 2002; 397: 298–304
   PubMed Web of Science ®Google Scholar
• Bulteau AL, Petropoulos I, Friguet B. Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 2000; 35: 767–777
   PubMedGoogle Scholar
• Carrard G, Dieu M, Raes M, Toussaint O, Friguet B. Impact of ageing on proteasome structure and function in human lymphocytes. Int J Biochem Cell Biol 2003; 35: 728–739
   PubMedGoogle Scholar
• Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547–581
   PubMed Web of Science ®Google Scholar
• Friguet B, Bulteau AL, Chondrogianni N, Conconi M, Petropoulos I. Protein degradation by the proteasome and its implications in aging. Ann N Y Acad Sci 2000; 908: 143–154
   PubMedGoogle Scholar
• Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 1997; 11: 526–534
   PubMed Web of Science ®Google Scholar
• Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci USA 1999; 96: 6223–6228
   PubMed Web of Science ®Google Scholar
• Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65: 801–847
   PubMed Web of Science ®Google Scholar
• Rivett AJ. Intracellular distribution of proteasomes. Curr Opin Immunol 1998; 10: 110–114
   PubMedGoogle Scholar
• Kopp F, Hendil KB, Dahlmann B, Kristensen P, Sobek A, Uerkvitz W. Subunit arrangement in the human 20S proteasome. Proc Natl Acad Sci USA 1997; 94: 2939–2944
   PubMed Web of Science ®Google Scholar
• Rechsteiner M, Realini C, Ustrell V. The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem J 2000; 345: 1–15
   PubMedGoogle Scholar
• Rechsteiner M, Hoffman L, Dubiel W. The multicatalytic and 26S proteases. J Biol Chem 1993; 268: 6065–6068
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: Mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J 1994; 8: 182–191
   PubMed Web of Science ®Google Scholar
• Voges D, Zwickl P, Baumeister W. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68: 1015–1068
   PubMed Web of Science ®Google Scholar
• Brooks P, Fuertes G, Murray RZ, Bose S, Knecht E, Rechsteiner MC, Hendil KB, Tanaka K, Dyson J, Rivett J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 2000; 346: 155–161
   PubMed Web of Science ®Google Scholar
• Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 1983; 258: 8206–8214
   PubMed Web of Science ®Google Scholar
• Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999; 96: 635–644
   PubMed Web of Science ®Google Scholar
• Dubiel W, Kloetzel PM. The 20S proteasome activator PA28 or 11S regulator. The world of regulatory proteolysis, W Hilt, DH Wolf. Eureka.com/Landes Bioscience, Georgetown 2000; 129–136
   Google Scholar
• Ma CP, Slaughter CA, DeMartino GN. Identification, purification and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J Biol Chem 1992; 267: 10515–10523
   PubMed Web of Science ®Google Scholar
• Hendil KB, Khan S, Tanaka K. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes. Biochem J 1998; 332: 749–754
   PubMed Web of Science ®Google Scholar
• Pacifici RE, Salo DC, Davies KJ. Macroxyproteinase (M.O.P.): A 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med 1989; 7: 521–536
   PubMed Web of Science ®Google Scholar
• Pacifici RE, Kono Y, Davies KJ. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 1993; 268: 15405–15411
   PubMed Web of Science ®Google Scholar
• Giulivi C, Pacifici RE, Davies KJ. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch Biochem Biophys 1994; 311: 329–341
   PubMed Web of Science ®Google Scholar
• Hough R, Pratt G, Rechsteiner M. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem 1987; 262: 8303–8313
   PubMed Web of Science ®Google Scholar
• Grune T, Reinheckel T, Joshi M, Davies KJ. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem 1995; 270: 2344–2351
   PubMed Web of Science ®Google Scholar
• Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem 1996; 271: 15504–15509
   PubMed Web of Science ®Google Scholar
• Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJ. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem 1998; 273: 10857–10862
   PubMed Web of Science ®Google Scholar
• Rivett AJ. Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. J Biol Chem 1985; 260: 300–305
   PubMedGoogle Scholar
• Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 1998; 335: 637–642
   PubMed Web of Science ®Google Scholar
• Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 2000; 377: 65–68
   PubMed Web of Science ®Google Scholar
• Shang F, Gong X, Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem 1997; 272: 23086–23093
   PubMedGoogle Scholar
• Jahngen-Hodge J, Obin MS, Gong X, Shang F, Nowell TR, Jr., Gong J, Abasi H, Blumberg J, Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 1997; 272: 28218–28226
   PubMed Web of Science ®Google Scholar
• Obin M, Shang F, Gong X, Handelman G, Blumberg J, Taylor A. Redox regulation of ubiquitin-conjugating enzymes: Mechanistic insights using the thiol-specific oxidant diamide. FASEB J 1998; 12: 561–569
   PubMed Web of Science ®Google Scholar
• Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278: 311–318
   PubMed Web of Science ®Google Scholar
• Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, Davies KJ. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 2000; 14: 1490–1498
   PubMed Web of Science ®Google Scholar
• Friguet B, Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett 1997; 405: 21–25
   PubMed Web of Science ®Google Scholar
• Friguet B, Stadtman ER, Szweda LI. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 1994; 269: 21639–21643
   PubMed Web of Science ®Google Scholar
• Kisselev AF, Akopian TN, Castillo V, Goldberg AL. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 1999; 4: 395–402
   PubMed Web of Science ®Google Scholar
• Johnston JA, Ward CL, Kopito RR. Aggresomes: A cellular response to misfolded proteins. J Cell Biol 1998; 143: 1883–1898
   PubMed Web of Science ®Google Scholar
• Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. Activity and regulation of the centrosome-associated proteasome. J Biol Chem 2000; 275: 409–413
   PubMed Web of Science ®Google Scholar
• Fink AL. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 1998; 3: R9–23
   PubMedGoogle Scholar
• Wetzel R. Mutations and off-pathway aggregation of proteins. Trends Biotechnol 1994; 12: 193–198
   PubMed Web of Science ®Google Scholar
• Davies KJ. Protein damage and degradation by oxygen radicals. I. General aspects. J Biol Chem 1987; 262: 9895–9901
   PubMed Web of Science ®Google Scholar
• Davies KJ, Delsignore ME, Lin SW. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem 1987; 262: 9902–9907
   PubMed Web of Science ®Google Scholar
• Davies KJ, Delsignore ME. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J Biol Chem 1987; 262: 9908–9913
   PubMed Web of Science ®Google Scholar
• Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem 1987; 262: 9914–9920
   PubMed Web of Science ®Google Scholar
• Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 1996; 21: 871–888
   PubMed Web of Science ®Google Scholar
• Yin D. Studies on age pigments evolving into a new theory of biological aging. Gerontology 1995; 41: 159–172
   PubMedGoogle Scholar
• Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol (Paris) 2003; 51: 569–573
   PubMedGoogle Scholar
• Ricciarelli R, Maroni P, Ozer N, Zingg JM, Azzi A. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med 1999; 27: 729–737
   PubMed Web of Science ®Google Scholar
• Khorramizadeh MR, Tredget EE, Telasky C, Shen Q, Ghahary A. Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Mol Cell Biochem 1999; 194: 99–108
   PubMed Web of Science ®Google Scholar
• Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: Relevance for photoaging and photodermatosis. J Dermatol Sci 2000; 23: 22–26
   PubMed Web of Science ®Google Scholar
• Wlaschek M, Briviba K, Stricklin GP, Sies H, Scharffetter-Kochanek K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol 1995; 104: 194–198
   PubMed Web of Science ®Google Scholar
• Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett 1993; 331: 304–306
   PubMed Web of Science ®Google Scholar
• Scharffetter K, Wlaschek M, Hogg A, Bolsen K, Schothorst A, Goerz G, Krieg T, Plewig G. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506–511
   PubMed Web of Science ®Google Scholar
• Sudel KM, Venzke K, Knussmann-Hartig E, Moll I, Stab F, Wenck H, Wittern KP, Gercken G, Gallinat S. Tight control of matrix metalloproteinase-1 activity in human skin. Photochem Photobiol 2003; 78: 355–360
   PubMed Web of Science ®Google Scholar
• Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337: 1419–1428
   PubMed Web of Science ®Google Scholar
• Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S, Voorhees JJ. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998; 101: 1432–1440
   PubMed Web of Science ®Google Scholar
• Dedieu S, Lefebvre P. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal 2006; 18: 889–898
   PubMed Web of Science ®Google Scholar
• Tanaka K, Hasegawa J, Asamitsu K, Okamoto T. Prevention of the ultraviolet B-mediated skin photoaging by a nuclear factor kappaB inhibitor, parthenolide. J Pharmacol Exp Ther 2005; 315: 624–630
   PubMed Web of Science ®Google Scholar
• Lavrovsky Y, Chatterjee B, Clark RA, Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000; 35: 521–532
   PubMed Web of Science ®Google Scholar
• Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 1987; 262: 5488–5491
   PubMed Web of Science ®Google Scholar
• Sander CS, Chang H, Salzmann S, Muller CS, Ekanayake-Mudiyanselage S, Elsner P, Thiele JJ. Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol 2002; 118: 618–625
   PubMed Web of Science ®Google Scholar
• Thiele JJ, Hsieh SN, Briviba K, Sies H. Protein oxidation in human stratum corneum: Susceptibility of keratins to oxidation in vitro and presence of a keratin oxidation gradient in vivo. J Invest Dermatol 1999; 113: 335–339
   PubMed Web of Science ®Google Scholar
• Grether-Beck S, Wlaschek M, Krutmann J, Scharffetter-Kochanek K. Photodamage and photoaging—prevention and treatment. J Dtsch Dermatol Ges 2005; 3: 19–25
   Google Scholar
• Fisher GJ. The pathophysiology of photoaging of the skin. Cutis 2005; 75: 5–8, discussion 8–9
   PubMed Web of Science ®Google Scholar
• Lopez-Torres M, Thiele JJ, Shindo Y, Han D, Packer L. Topical application of alpha-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. Br J Dermatol 1998; 138: 207–215
   PubMed Web of Science ®Google Scholar
• Bulteau AL, Moreau M, Nizard C, Friguet B. Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. Free Radic Biol Med 2002; 32: 1157–1170
   PubMedGoogle Scholar
• Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, Milner Y, Friguet B. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 2000; 55: B220–B227
   PubMedGoogle Scholar
• Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 2000; 35: 721–728
   PubMed Web of Science ®Google Scholar
• Hayflick L. The cell biology of human aging. N Engl J Med 1976; 295: 1302–1308
   PubMed Web of Science ®Google Scholar
• Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nature Biotech 2002; 20: 682–688
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress in cell culture: An under-appreciated problem?. FEBS Lett 2003; 540: 3–6
   PubMed Web of Science ®Google Scholar
• Sitte N, Merker K, von Zglinicki T, Grune T. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic Biol Med 2000; 28: 701–708
   PubMed Web of Science ®Google Scholar
• Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478
   PubMed Web of Science ®Google Scholar
• Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233: 346–357
   PubMed Web of Science ®Google Scholar
• Sitte N, Merker K, Von Zglinicki T, Grune T, Davies KJ. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: Part I—effects of proliferative senescence. FASEB J 2000; 14: 2495–2502
   PubMed Web of Science ®Google Scholar
• Sitte N, Merker K, Von Zglinicki T, Davies KJ, Grune T. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: Part II—aging of nondividing cells. FASEB J 2000; 14: 2503–2510
   PubMed Web of Science ®Google Scholar
• Merker K, Sitte N, Grune T. Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. Arch Biochem Biophys 2000; 375: 50–54
   PubMedGoogle Scholar
• Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJ, Katzeff H. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 2005; 38: 1093–1101
   PubMed Web of Science ®Google Scholar
• Ly DH, Lockhart DJ, Lerner RA, Schultz PG. Mitotic misregulation and human aging. Science 2000; 287: 2486–2492
   PubMed Web of Science ®Google Scholar
• Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 2001; 276: 30057–30063
   PubMed Web of Science ®Google Scholar
• Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab 2000; 20: 1467–1473
   PubMed Web of Science ®Google Scholar
• Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K. 4-Hydroxy-2-nonennal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 1999; 274: 23787–23793
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES. Central role of the proteasome in senescence and survival of human fibroblasts: Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 2003; 278: 28026–28037
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Gonos ES. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology 2004; 5: 55–61
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 2001; 928: 22–38
   PubMed Web of Science ®Google Scholar
• Levine RL, Stadtman ER. Oxidative modification of proteins during aging. Exp Gerontol 2001; 36: 1495–1502
   PubMed Web of Science ®Google Scholar
• Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313–20316
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220–1224
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: Where are we now?. J Neurochem 2006; 97: 1634–1658
   PubMed Web of Science ®Google Scholar
• Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd RA. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci USA 1991; 88: 3633–3636
   PubMed Web of Science ®Google Scholar
• Schipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 2004; 3: 265–301
   PubMed Web of Science ®Google Scholar
• Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002; 23: 795–807
   PubMed Web of Science ®Google Scholar
• Floyd RA, Carney JM. Age influence on oxidative events during brain ischemia/reperfusion. Arch Gerontol Geriatr 1991; 12: 155–177
   PubMed Web of Science ®Google Scholar
• Floyd RA, Carney JM. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992; 32: S22–S27
   PubMed Web of Science ®Google Scholar
• Zaleska MM, Nagy K, Floyd RA. Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes. Neurochem Res 1989; 14: 597–605
   PubMedGoogle Scholar
• Zaleska MM, Floyd RA. Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron. Neurochem Res 1985; 10: 397–410
   PubMed Web of Science ®Google Scholar
• Hensley K, Maidt L, Stewart CA, Pye QN, Robinson KA, Floyd RA. Mitochondrial alteration in aging and inflammation: A possible site of action of nitrone-based free radical traps. Understanding the process of aging the roles of mitochondria, free radicals, and antioxidants, E Cadenas, L Packer. Marcel Dekker, New York 1999; 311–325
   Google Scholar
• Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann N Y Acad Sci 2004; 1033: 108–116
   PubMed Web of Science ®Google Scholar
• Ames BN. Delaying the mitochondrial decay of aging. Ann N Y Acad Sci 2004; 1019: 406–411
   PubMedGoogle Scholar
• Grune T, Davies KJA. Oxidative processes in aging. Handbook of the biology of aging5th ed. Academic Press. 2001; 25–58
   Google Scholar
• Goldbaum O, Vollmer G, Richter-Landsberg C. Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes. Glia 2006; 53: 891–901
   PubMedGoogle Scholar
• Ding Q, Martin S, Dimayuga E, Bruce-Keller AJ, Keller JN. LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid Redox Signal 2006; 8: 130–135
   PubMed Web of Science ®Google Scholar
• Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999; 285: 1390–1393
   PubMed Web of Science ®Google Scholar
• Ly DH, Lockhart DJ, Lerner RA, Schultz PG. Mitotic misregulation and human aging. Science 2000; 287: 2486–2492
   PubMed Web of Science ®Google Scholar
• Bardag-Gorce F, Farout L, Veyrat-Durebex C, Briand Y, Briand M. Changes in 20S proteasome activity during ageing of the LOU rat. Mol Biol Rep 1999; 26: 89–93
   PubMedGoogle Scholar
• Dubiel W, Ferrell K, Rechsteiner M. Subunits of the regulatory complex of the 26S protease. Mol Biol Rep 1995; 21: 27–34
   PubMedGoogle Scholar
• Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 2005; 391: 59–67
   PubMed Web of Science ®Google Scholar
• Gregori L, Fuchs C, Figueiredo-Pereira ME, Van Nostrand WE, Goldgaber D. Amyloid beta protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem 1995; 270: 19702–19708
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131–1135
   PubMed Web of Science ®Google Scholar
• Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987; 235: 877–880
   PubMed Web of Science ®Google Scholar
• Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–736
   PubMed Web of Science ®Google Scholar
• Gregori L, Hainfeld JF, Simon MN, Goldgaber D. Binding of amyloid beta protein to the 20S proteasome. J Biol Chem 1997; 272: 58–62
   PubMed Web of Science ®Google Scholar
• Mori H, Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987; 235: 1641–1644
   PubMed Web of Science ®Google Scholar
• Perry G, Friedman R, Shaw G, Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci USA 1987; 84: 3033–3036
   PubMed Web of Science ®Google Scholar
• McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1991; 30: 156–165
   PubMed Web of Science ®Google Scholar
• Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988; 132: 86–101
   PubMed Web of Science ®Google Scholar
• Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997; 23: 134–147
   PubMed Web of Science ®Google Scholar
• Smith MA. Alzheimer disease. Int Rev Neurobiol 1998; 42: 1–54
   PubMed Web of Science ®Google Scholar
• Shringarpure R, Grune T, Sitte N, Davies KJ. 4-Hydroxynonennal-modified amyloid-beta peptide inhibits the proteasome: Possible importance in Alzheimer's disease. Cell Mol Life Sci 2000; 57: 1802–1809
   PubMed Web of Science ®Google Scholar
• Munch G, Thome J, Foley P, Schinzel R, Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev 1997; 23: 134–143
   PubMed Web of Science ®Google Scholar
• Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996; 14: 649–683
   PubMed Web of Science ®Google Scholar
• Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 1997; 94: 2642–2647
   PubMed Web of Science ®Google Scholar
• Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989; 24: 173–182
   PubMed Web of Science ®Google Scholar
• Carpenter AF, Carpenter PW, Markesbery WR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 1993; 52: 601–608
   PubMedGoogle Scholar
• DiPatre PL, Gelman BB. Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol 1997; 56: 143–149
   PubMed Web of Science ®Google Scholar
• McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993; 7: 84–92
   PubMed Web of Science ®Google Scholar
• Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 2003; 85: 115–122
   PubMed Web of Science ®Google Scholar
• Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer's disease. J Neurochem 2000; 75: 436–439
   PubMed Web of Science ®Google Scholar
• Schapira AH. Nuclear and mitochondrial genetics in Parkinson's disease. J Med Genet 1995; 32: 411–414
   PubMedGoogle Scholar
• Duvoisin RC. Recent advances in the genetics of Parkinson's disease. Adv Neurol 1996; 69: 33–40
   PubMedGoogle Scholar
• Rideout HJ, Dietrich P, Wang Q, Dauer WT, Stefanis L. Alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons. J Biol Chem 2004; 279: 46915–46920
   PubMedGoogle Scholar
• Lee FJ, Liu F, Pristupa ZB, Niznik HB. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 2001; 15: 916–926
   PubMed Web of Science ®Google Scholar
• Wersinger C, Prou D, Vernier P, Sidhu A. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 2003; 17: 2151–2153
   PubMed Web of Science ®Google Scholar
• Wersinger C, Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett 2003; 340: 189–192
   PubMed Web of Science ®Google Scholar
• Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 2002; 277: 38884–38894
   PubMed Web of Science ®Google Scholar
• George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995; 15: 361–372
   PubMed Web of Science ®Google Scholar
• Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002; 3: 932–942
   PubMed Web of Science ®Google Scholar
• Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 1998; 392: 605–608
   PubMed Web of Science ®Google Scholar
• Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395: 451–452
   PubMed Web of Science ®Google Scholar
• Lang-Rollin I, Rideout H, Stefanis L. Ubiquitinated inclusions and neuronal cell death. Histol Histopathol 2003; 18: 509–517
   PubMedGoogle Scholar
• Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 2004; 279: 12924–12934
   PubMed Web of Science ®Google Scholar
• Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem 2003; 278: 11753–11759
   PubMed Web of Science ®Google Scholar
• Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72: 355–363
   PubMed Web of Science ®Google Scholar
• Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 1998; 57: 338–342
   PubMed Web of Science ®Google Scholar
• Qureshi GA, Baig S, Bednar I, Sodersten P, Forsberg G, Siden A. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport 1995; 6: 1642–1644
   PubMed Web of Science ®Google Scholar
• Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P, Agid Y, Dugas B, Hirsch EC. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 1999; 19: 3440–3447
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J. Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson's disease. FASEB J 2005; 19: 533–542
   PubMed Web of Science ®Google Scholar